Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHILL-BAO
NCT07896655Not yet recruiting
- Sponsor
- Guangdong Second Provincial General Hospital
- Start
- Dec 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Randomised, single-blind trial of saline in basilar artery occlusion (BAO) (2 arms), sponsored by Guangdong Second Provincial General Hospital. Primary endpoint: Modified Rankin Scale Score at 90 days. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
saline
03
Conditions
basilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT07896655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07896655.